ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ODX Omega Diagnostics Group Plc

2.20
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.20 2.00 2.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Omega Diagnostics Share Discussion Threads

Showing 2776 to 2798 of 37200 messages
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older
DateSubjectAuthorDiscuss
29/1/2019
10:22
likitorma,

I think in this case stakeholders are shareholders, the only other interested party would be the Burnet Institute who will probably receive royalties from each test sold...there are no loan notes that I know of, so no other interested parties.....imo

barrywhit
29/1/2019
09:34
Word of caution: Stakeholders are not necessarily shareholders.
likitorma
29/1/2019
09:20
Good to see the Key shareholders are in constant contact with the company:

Colin King, Chief Executive of the Group, commented: "I am pleased to announce that we continue to deliver against our timeline for the VISITECT(R) CD4 Advanced Disease test. I am also encouraged by the outlook for this product as key stakeholders continue to engage with us about the sizeable opportunity once we bring the test to market."

barrywhit
29/1/2019
08:28
At last a positive RNS...
barrywhit
29/1/2019
07:42
Need financial indications.
likitorma
29/1/2019
07:33
Very good progress.
verger
28/1/2019
10:49
You're back after your break Dibs. Good timing on your sale a while back. I've lost track on what's happening with the WHO approval. Do you still have a handle on the timeline? It's been as slow as treacle while you were away, though you missed the ex-chairman trying to throw his weight around.
gwr7
25/1/2019
13:38
OK maybe it was a tree shake
dibs61
24/1/2019
17:19
I'm guessing Evans went because someone with clout tired of the 3F strategy - Fantasise, Fundraise then Flannel (rinse shareholders and repeat).
gwr7
24/1/2019
14:03
You are not supposed to say things like that on here
buywell3
24/1/2019
12:24
Sudden drop today. Suspicious. Placing coming?
dibs61
23/1/2019
10:57
Moving up.
likitorma
22/1/2019
18:33
The rise started with the £20k purchase(151k @13.25)@ 16.05....
barrywhit
22/1/2019
17:37
Arthur, I can't imagine anyone is ramping this company.....
barrywhit
22/1/2019
17:22
No idea but I'm all for a bit of excitement at the end of the day, the late trades though are not the norm here, let us see what tomorrow brings if anything?
hyperboreus
22/1/2019
17:12
Nothing to do with me, a bit of an unusual flurry, I wonder if it's being ramped somewhere.
arthur_lame_stocks
22/1/2019
17:06
I am hoping that wasn't you at it again Arthur in the last half hour of trading? 😂
hyperboreus
21/1/2019
18:33
I would imagine the large holders wanted to see a new broom...the company had not really progressed in a way to satisfy long term shareholders...
barrywhit
21/1/2019
17:10
So do I Arthur, incidentally during your conversation with our former non-exec Chairman did you get the feeling that David Evans resigned due to external pressure being exerted from those 'big shareholders'?

It was only last August for instance that he stated:

"As we move forward we have a difficult balancing act to maintain in terms of keeping the core business moving along whilst successfully executing our strategic priorities. That challenge should not be underestimated in terms of management stretch but I know that we have a good team here and they are up to that challenge.

"I am confident that we can deliver on the goals we have set with emphasis on realising in part value for shareholders. I am also confident that we can deliver on CD4 and I look forward to updating you as we progress throughout the year

"Ultimately, we are judged by our results and it may end up being a rather circuitous route to success, but I do believe that after many years of famine shareholders will see some bread in their basket by this time next year. The key thereafter will be to replenish that basket. I am confident we can achieve both."

....then in his interim statement outlook last December:

"Our short-term outlook is dominated by our efforts to realise value for Shareholders whilst at the same time successfully accelerating our efforts to commercialise our CD4 offering. The challenges are not inconsequential but I remain confident that in those areas where we can control our own destiny that we will succeed in delivering our objectives. In those areas where we are not masters of our own destiny then, by definition, the outcome will always be less certain. I believe it is best for our statement to reflect that reality as it stands today. Rest assured we will continue to work towards achieving success for all our Stakeholders."

ONE WEEK LATER, he resigns, I can only assume that he must have had major misgivings either about the way ODX was heading and/or the increasingly unwelcome influence of the big two!

hyperboreus
21/1/2019
16:25
I bought a few more, I just hope my faith isn't misplaced.
arthur_lame_stocks
19/1/2019
13:02
A bit like a few of us on here Arthur! 😂
hyperboreus
19/1/2019
12:44
I'm thinking of buying a few more of these, as I believe that the current price doesn't even reflect the value of the Food Intolerance business, let alone the potential of CD4.

I also think this is the belief of the two big holders and I think they'll push for a sale of Food Intolerance and maybe a return of some cash with some kept back to invest in CD4.

I'm hoping for some good news this year, from speaking to David Evans I got the impression that one of the big shareholders in particular is getting impatient.

arthur_lame_stocks
18/1/2019
16:04
Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries


barrywhit
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older

Your Recent History

Delayed Upgrade Clock